Overview

Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line Therapy

Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To compare the efficacy and tolerability of levofloxacin-based sequential therapy and triple therapy in the second line therapy for those who fail from one eradication therapy
Phase:
Phase 4
Details
Lead Sponsor:
National Taiwan University Hospital
Collaborator:
E-DA Hospital
Treatments:
Amoxicillin
Dexlansoprazole
Lansoprazole
Levofloxacin
Ofloxacin